{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:49:08Z","timestamp":1790891348889,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.medcli.2024.05.019","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T04:21:21Z","timestamp":1720930881000},"page":"375-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Anti-factor H autoantibodies in patients with lupus nephritis"],"prefix":"10.1016","volume":"163","author":[{"given":"Galya","family":"Mihaylova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasil","family":"Vasilev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Kosturkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Petkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Radanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2024.05.019_bib0170","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2012.08.018","article-title":"Lupus nephritis: a critical review","volume":"12","author":"Borchers","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.medcli.2024.05.019_bib0175","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000431278","article-title":"Complement in lupus nephritis: new perspectives","volume":"2","author":"Bao","year":"2015","journal-title":"Kidney Dis (Basel)"},{"key":"10.1016\/j.medcli.2024.05.019_bib0180","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fimmu.2013.00117","article-title":"Anti-C1q autoantibodies, novel tests, and clinical consequences","volume":"4","author":"Mahler","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.medcli.2024.05.019_bib0185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2215\/CJN.03990415","article-title":"Relationship of circulating anti-C3b and anti-C1q IgG to lupus nephritis and its flare","volume":"11","author":"Birmingham","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.medcli.2024.05.019_bib0190","doi-asserted-by":"crossref","first-page":"25343","DOI":"10.1074\/jbc.M115.647008","article-title":"Functional characterization of autoantibodies against complement component C3 in patients with lupus nephritis","volume":"290","author":"Vasilev","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.medcli.2024.05.019_bib0195","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/cei.13443","article-title":"Clinical and functional consequences of anti-properdin autoantibodies in patients with lupus nephritis","volume":"201","author":"Radanova","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.medcli.2024.05.019_bib0200","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system part I \u2013 molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.medcli.2024.05.019_bib0205","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2004050380","article-title":"Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.medcli.2024.05.019_bib0210","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrneph.2016.99","article-title":"Anti-complement-factor H-associated glomerulopathies","volume":"12","author":"Durey","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.medcli.2024.05.019_bib0215","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.4049\/jimmunol.1402770","article-title":"Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases","volume":"194","author":"Blanc","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.medcli.2024.05.019_bib0220","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1186\/ar4016","article-title":"Factor H autoantibodies and deletion of complement factor H-related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome","volume":"14","author":"Foltyn Zadura","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.medcli.2024.05.019_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2020.05.005","article-title":"Anti-complement factor H autoantibodies may be protective in lupus nephritis","volume":"508","author":"Li","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.medcli.2024.05.019_bib0230","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.medcli.2024.05.019_bib0235","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/rheumatology\/keh624","article-title":"BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus","volume":"44","author":"Isenberg","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.medcli.2024.05.019_bib0240","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"15","author":"Weening","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.medcli.2024.05.019_bib0245","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ki.1994.70","article-title":"Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data","volume":"45","author":"Austin","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.medcli.2024.05.019_bib0250","doi-asserted-by":"crossref","first-page":"450351","DOI":"10.1155\/2015\/450351","article-title":"Antibodies against C1q are a valuable serological marker for identification of systemic lupus erythematosus patients with active lupus nephritis","volume":"2015","author":"Chi","year":"2015","journal-title":"Dis Markers"},{"key":"10.1016\/j.medcli.2024.05.019_bib0255","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3389\/fimmu.2018.01607","article-title":"Self-damage caused by dysregulation of the complement alternative pathway: relevance of the factor H protein family","volume":"9","author":"S\u00e1nchez-Corral","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.medcli.2024.05.019_bib0260","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3389\/fimmu.2018.00559","article-title":"Complement factor H inhibits anti-neutrophil cytoplasmic autoantibody-induced neutrophil activation by interacting with neutrophils","volume":"9","author":"Chen","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.medcli.2024.05.019_bib0265","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1093\/rheumatology\/kes218","article-title":"Serum complement factor H is associated with clinical and pathological activities of patients with lupus nephritis","volume":"51","author":"Wang","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.medcli.2024.05.019_bib0270","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/ndt\/gfp388","article-title":"Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome","volume":"25","author":"Strobel","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.medcli.2024.05.019_bib0275","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3389\/fimmu.2019.01282","article-title":"Clinical and immunological profile of anti-factor H antibody associated atypical hemolytic uremic syndrome: a nationwide database","volume":"10","author":"Puraswani","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.medcli.2024.05.019_bib0280","doi-asserted-by":"crossref","first-page":"e60352","DOI":"10.1371\/journal.pone.0060352","article-title":"Determining the population frequency of the CFHR3\/CFHR1 deletion at 1q32","volume":"8","author":"Holmes","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.medcli.2024.05.019_bib0285","first-page":"11","article-title":"Impact of autoantibodies to complement components on the disease activity in SLE","volume":"69","author":"Pradhan","year":"2021","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.medcli.2024.05.019_bib0290","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.amjms.2017.01.005","article-title":"Complement alternative pathway's activation in patients with lupus nephritis","volume":"353","author":"Song","year":"2017","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.medcli.2024.05.019_bib0295","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s12026-023-09396-y","article-title":"Anti-complement factor H (CFH) autoantibodies could delay pristane-induced lupus nephritis","volume":"71","author":"Li","year":"2023","journal-title":"Immunol Res"},{"key":"10.1016\/j.medcli.2024.05.019_bib0300","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s13730-021-00627-5","article-title":"Thrombotic microangiopathy in a patient with systemic lupus erythematosus and anti-factor H autoantibodies","volume":"11","author":"Figueiredo","year":"2022","journal-title":"CEN Case Rep"},{"key":"10.1016\/j.medcli.2024.05.019_bib0305","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1007\/s10067-017-3823-2","article-title":"Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review","volume":"36","author":"de Holanda","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.medcli.2024.05.019_bib0310","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1002\/art.21252","article-title":"Protective autoantibodies: role in homeostasis, clinical importance, and therapeutic potential","volume":"52","author":"Shoenfeld","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.medcli.2024.05.019_bib0315","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1158\/1078-0432.CCR-10-0321","article-title":"Complement factor H autoantibodies are associated with early stage NSCLC","volume":"16","author":"Amornsiripanitch","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.medcli.2024.05.019_bib0320","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1158\/2326-6066.CIR-15-0122","article-title":"Complement factor H antibodies from lung cancer patients induce complement-dependent lysis of tumor cells, suggesting a novel immunotherapeutic strategy","volume":"3","author":"Campa","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.medcli.2024.05.019_bib0325","doi-asserted-by":"crossref","first-page":"2328433","DOI":"10.1080\/2162402X.2024.2328433","article-title":"Humoral complementomics \u2013 exploration of noninvasive complement biomarkers as predictors of renal cancer progression","volume":"13","author":"Revel","year":"2024","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.medcli.2024.05.019_bib0330","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.3899\/jrheum.150185","article-title":"Factor H autoantibodies in patients with antiphospholipid syndrome and thrombosis","volume":"42","author":"Foltyn","year":"2015","journal-title":"J Rheumatol"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324003889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324003889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T06:28:48Z","timestamp":1729319328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775324003889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0025775324003889"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2024.05.019","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-factor H autoantibodies in patients with lupus nephritis","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2024.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}